Yuchuan Jiang
Department of Hepatobiliary Surgery,
The First Affiliated Hospital,
Department of Hepatobiliary Surgery, The First Affiliated Hospital
jinan university
Yuchuan Jiang has not added Biography.
If you are Yuchuan Jiang and would like to personalize this page please email our Author Liaison for assistance.
CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression.
Frontiers in immunology , 2017 | Pubmed ID: 29255466
Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation.
Experimental & molecular medicine Jul, 2020 | Pubmed ID: 32632241
Pyruvate Kinase M2 Tetramerization Protects against Hepatic Stellate Cell Activation and Liver Fibrosis.
The American journal of pathology Nov, 2020 | Pubmed ID: 32805235
Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness.
Cancer cell international Dec, 2020 | Pubmed ID: 33372604
Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activation.
Journal of cellular and molecular medicine Feb, 2021 | Pubmed ID: 33410581
Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model.
Hepatology (Baltimore, Md.) 07, 2021 | Pubmed ID: 33609283
TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
Frontiers in immunology , 2021 | Pubmed ID: 33679751
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2022 | Pubmed ID: 36525610
Serine/threonine kinase TBK1 promotes cholangiocarcinoma progression via direct regulation of β-catenin.
Oncogene May, 2023 | Pubmed ID: 36928362
A novel prognostic biomarker: is correlated with methylation and immune escape in liver hepatocellular carcinoma.
Translational cancer research May, 2023 | Pubmed ID: 37304536
Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for hepatocellular carcinoma.
Hepatology (Baltimore, Md.) Oct, 2023 | Pubmed ID: 37820061
GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.
Journal of cellular physiology May, 2024 | Pubmed ID: 38468464
Laparoscopic Posterior Radical Antegrade Modular Pancreatosplenectomy for Distal Pancreatic Carcinoma
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Qiang Li*,1,
Xiaolan Wang*,1,2,
Deju Li*,1,
Yulong Liu*,3,
Kangshou Liu1,
Junjie Liang1,
Jian Sun1,
Quan Jiang1,
Jiexing Li1,
Zhilong Liu1,
Jian Gong4,
Leyang Xiang1,
Zhidong Jia1,
Zhiwei Chen1,
Mingrong Cao1,
Yuchuan Jiang1,5
1Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University,
2Dongpu Branch, The First Affiliated Hospital, Jinan University,
3Department of Vascular Intervention, The First Affiliated Hospital, Jinan University,
4Department of Nuclear Medicine, The First Affiliated Hospital, Jinan University,
5Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University
版权所属 © 2025 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。
我们使用 cookie 来增强您在我们网站上的体验。
继续使用我们的网站或单击“继续”，即表示您同意接受我们的 cookie。